Golden Lee Scott 4

What Happened
Golden Lee Scott, EVP and Chief Medical Officer of PTC Therapeutics (PTCT), sold 829 shares on 2026-04-02 at $67.99 per share, for a total value of $56,364. The sale was a sell-to-cover transaction tied to RSU vesting (not a discretionary market-timing sale).

Key Details

• Transaction date and price: 2026-04-02 — 829 shares sold at $67.99 each.
• Total proceeds: $56,364.
• Shares owned after transaction: Not reported in the Form 4 filing.
• Footnote: The shares were automatically sold pursuant to an irrevocable sell-to-cover election to satisfy tax withholding for the vesting of 2,100 RSUs from an April 24, 2023 grant of 8,400 RSUs.
• Filing timeliness: Report filed 2026-04-06, within the required two business days (timely).

Context
A sell-to-cover is a routine automatic sale to cover tax obligations when RSUs vest; it generally reflects tax logistics rather than a change in the insider's view of the company. This was a sale (code S) tied to tax withholding, not a purchase or speculative move.